Trials / Completed
CompletedNCT04124328
Evaluation of Vein of Marshall Ethanol Infusion During Left Atrial Linear Ablation in Patients With Persistent Atrial Fibrillation
The MARSHALINE Study: Evaluation of Vein of Marshall Ethanol Infusion During Left Atrial Linear Ablation in Patients With Persistent Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- AZ Sint-Jan AV · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this prospective, randomized, controlled, unblinded, mono-center study, we aim to evaluate the efficacy of vein of Marshall ethanol infusion during left atrial linear ablation in patients with atrial fibrillation compared to the ALINE protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ALINE + VoM infusion | In patients assigned to the ALINE + VoM infusion group, extended ablation will be performed according to the ALINE criteria. Additionally, the vein of Marshall will be infused with ethanol. |
| PROCEDURE | ALINE only | In patients assigned to the ALINE only, extended ablation will be performed according to the ALINE criteria. |
Timeline
- Start date
- 2019-10-15
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2019-10-11
- Last updated
- 2022-08-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04124328. Inclusion in this directory is not an endorsement.